$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 16, 2025)
$10.95M
Market Cap
-
P/E Ratio
-13.91
EPS
$49.11
52 Week High
$0.37
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
AEON Biopharma, Inc., based in Newport Beach, California, is at the forefront of the biopharmaceutical sector, specializing in the development of advanced botulinum toxin products aimed at addressing a range of debilitating medical conditions. The company stands out with its emphasis on proprietary formulations, strategically positioning itself within the growing neuromodulators market. AEON's innovative pipeline and commitment to enhancing treatment outcomes not only underscore its potential for significant market impact but also highlight its role as a key player in shaping the future of therapeutic and aesthetic interventions. As the demand for effective solutions continues to rise, AEON is well-equipped to capitalize on emerging opportunities in the evolving healthcare landscape.
LPTX
IVP
VMAR
CGC
WOK
NVDA
PFE
IRBT
TSLA
PLUG
RZLV
ASST
ADAP
AAL
F
PLTD
HPE
SOFI
AVGO
TLRY
BITF
IREN
BYND
WBD
MSTR
PLTR
CPNG
INTC
DNN
CIFR
MARA
RIG
KDLY
GRAB
SNAP
PBR
ORCL
FI
RXRX
TTD
ITUB
CFLT
TSLG
NIO
WULF
KIND
BLNK
PINS
LAZR
AGNC
RKLB
RGTI
NFLX
GOOGL
VHAI
SHOT
RR
T
ZAPP
AMD
HOOD
NOK
VALE
DVLT
BTBT
CLSK
LPTX
IVP
VMAR
CGC
WOK
NVDA
PFE
IRBT
TSLA
PLUG
RZLV
ASST
ADAP
AAL
F
PLTD
HPE
SOFI
AVGO
TLRY
BITF
IREN
BYND
WBD
MSTR
PLTR
CPNG
INTC
DNN
CIFR
MARA
RIG
KDLY
GRAB
SNAP
PBR
ORCL
FI
RXRX
TTD
ITUB
CFLT
TSLG
NIO
WULF
KIND
BLNK
PINS
LAZR
AGNC
RKLB
RGTI
NFLX
GOOGL
VHAI
SHOT
RR
T
ZAPP
AMD
HOOD
NOK
VALE
DVLT
BTBT
CLSK